Logo Logo Logo Logo Logo
  • Home
  • About us
    • Leadership Council
  • National Grants
  • Resources
  • News & Events
  • Gallery & Media Corner
  • Contact
  • Donate
  • Home
  • About us
    • Leadership Council
  • National Grants
  • Resources
  • News & Events
  • Gallery & Media Corner
  • Contact
  • Donate
viiv logo RGB

31 Jan Press Release: European Commission authorises ViiV Healthcare’s long-acting injectable Vocabria + Rekambys for HIV treatment in adolescents.

Posted at 23:18h in Latest News by Olwethu Mlanzeli
ViiV Healthcare_V+R Adolescents EC Marketing Authorisation_310125Download PRESS RELEASE



Home
About us
Leadership Council
News and Events
Contact


Partners
DTHF   EGPAF

Supported by ViiV Healthcare Positive Action and the Johnson & Johnson Foundation

Newsletter Sign Up
Africa Reaching the End of AIDS in Children and Young People by 2025.




    Get in touch
    info@africareach.org
    3 Woodlands Road, Woodstock
    Cape Town, South Africa
    Managed by Pomegranite